Purchase Order 75N92025P00241
Award Date
6/24/25
Potential Completion Date
12/23/25
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Olink Proteomics Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The $19,785.63 firm-fixed-price purchase order is for Olink assay kits to enable the agency to use their existing Olink equipment and avoid the expense of having samples analyzed by Olink. This award does not have a set-aside designation. Olink Proteomics is...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $24,424.80, is for Olink to provide proteomics assays to support an NHLBI research project investigating the link between plasma myokine abundance and physical capacity in patients with non-tuberculous mycobacterial...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $10,558 firm-fixed-price purchase order is for the delivery of Olink's proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical research missions spanning aging, cancer, neurodegenerative diseases, diabetes, infectious diseases, and more. Olink...
This federal contract award, valued at $10,558.00, was issued by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company based in Waltham, Massachusetts. The contract is for a service agreement to provide the Olink Signature Q100 System, which is an advanced proteomics instrument used for protein biomarker discovery and analysis. The contract has a period of performance from August 5, 2025 to August 4, 2026 and is a firm...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...
This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $98,392.48 contract is for the delivery of the Olink Explore 3072 Proteomics Screening Kit, which supports the agency's biomedical research missions in areas such as aging, cancer, and neurodegenerative diseases. Olink Proteomics has a significant...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
The National Institutes of Health (NIH) Clinical Center's Critical Care Medicine Department (CCMD) has awarded a firm-fixed-price purchase order contract valued at $44,646.78 to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company based in Waltham, Massachusetts. The contract is for the procurement of Olink Signature Q100 system reagents, including Olink Target 96 Inflammation, Olink 96.96 IFC for Protein Expression, and Olink Target 96 Organ Damage reagents. These reagents...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for the provision of the OLINK SIGNATURE Q100 STARTER KIT AND REAGENTS. The contract is a firm-fixed-price purchase order with a potential value of $187,601.80 and a completion date of August 22, 2023. No set-aside designation was used for this award. Olink Proteomics has received...
This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...